Involvement of SRF coactivator MKL2 in BDNF-mediated activation of the synaptic activity-responsive element in the Arc gene

Journal of Neurochemistry
Keietsu KikuchiAkiko Tabuchi

Abstract

The expression of immediate early genes (IEGs) is thought to be an essential molecular basis of neuronal plasticity for higher brain function. Many IEGs contain serum response element in their transcriptional regulatory regions and their expression is controlled by serum response factor (SRF). SRF is known to play a role in concert with transcriptional cofactors. However, little is known about how SRF cofactors regulate IEG expression during the process of neuronal plasticity. We hypothesized that one of the SRF-regulated neuronal IEGs, activity-regulated cytoskeleton-associated protein (Arc; also termed Arg3.1), is regulated by an SRF coactivator, megakaryoblastic leukemia (MKL). To test this hypothesis, we initially investigated which binding site of the transcription factor or SRF cofactor contributes to brain-derived neurotrophic factor (BDNF)-induced Arc gene transcription in cultured cortical neurons using transfection and reporter assays. We found that BDNF caused robust induction of Arc gene transcription through a cAMP response element, binding site of myocyte enhancer factor 2, and binding site of SRF in an Arc enhancer, the synaptic activity-responsive element (SARE). Regardless of the requirement for the SRF-binding...Continue Reading

References

Oct 25, 2002·Proceedings of the National Academy of Sciences of the United States of America·Da-Zhi WangEric N Olson
May 7, 2003·Cell·Francesc MirallesRichard Treisman
Dec 25, 2003·Gene·Gilles BuchwalterBohdan Wasylyk
Jul 23, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Almira Vazdarjanova, John F Guzowski
Apr 20, 2005·Proceedings of the National Academy of Sciences of the United States of America·Siegfried AlbertiAlfred Nordheim
May 10, 2005·Nature Neuroscience·Narendrakumar RamananDavid D Ginty
Jun 15, 2005·Journal of Neurochemistry·Akiko TabuchiJay M Baraban
Jan 18, 2006·Nature Neuroscience·Bernd KnöllAlfred Nordheim
May 30, 2006·Nature Neuroscience·Vikram R RaoSteven Finkbeiner
Sep 29, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Katarzyna KalitaMichal Hetman
Jan 1, 2009·Proceedings of the National Academy of Sciences of the United States of America·Takashi KawashimaHaruhiko Bito
Feb 6, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Sean A PintchovskiSteven Finkbeiner
Nov 10, 2009·Behavior Research Methods·Franz FaulAlbert-Georg Lang
Dec 18, 2009·Cerebral Cortex·Niamh C O'SullivanKeith J Murphy
May 6, 2010·European Journal of Human Genetics : EJHG·Richard HoltUNKNOWN EU Autism MOLGEN Consortium
Aug 10, 2010·Nature Neuroscience·Constance Smith-HicksDavid J Linden
May 26, 2012·The International Journal of Biochemistry & Cell Biology·Katarzyna KalitaLeszek Kaczmarek
Jun 10, 2014·Scientific Reports·Mineyuki MizuguchiAkiko Tabuchi
Nov 9, 2014·Schizophrenia Bulletin·Xiong-Jian LuoYong-Gang Yao

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Brain Injury & Trauma

brain injury after impact to the head is due to both immediate mechanical effects and delayed responses of neural tissues.